Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of April 11, 2021
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
There’s no crystal ball for modeling the pandemic
Mathematical modelers explain challenges, limitations of their work to predict COVID-19 outcomes
Modeling the kinetics of an HIV cure
From the Schiffer group, Vaccine and Infectious Disease Division
Vaccines stop COVID-19 symptoms, but do they stop transmission?
Researchers mull options, including college dorm studies and 'human challenge' trials, to find answer
Celebrate safely: Scientists offer advice, urge vigilance during holidays
'Now is the time for delayed gratification' — so skip big gatherings and travel to prevent the spread of COVID-19
From the freezers, a speedier way to evaluate antiviral drugs
Lookback research showed today’s ‘viral load’ measurements and machine learning quickly mirrored outcomes of older, slower trials
Imperfect, widely used measures best option against COVID-19, argues Dr. Joshua Schiffer
We need tests, masks, treatments and vaccines to be widespread, not perfect, says infectious disease expert in New York Times editorial
Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more
Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
Computer model offers insights on COVID-19 super-spreading
New research compares transmission patterns of SARS-CoV-2 with those of influenza
Fred Hutch and University of Washington experts: Treat COVID-19 earlier to save lives
New review article in Open Forum Infectious Diseases suggests “golden opportunity being missed”
Antiviral cytokines pick up T cell slack
From the Schiffer group, Vaccine and Infectious Disease Division
Scientists strategize to stop HIV infections, work toward cure
A hot topic for a big scientific conference convening in Seattle
Models identify cellular proliferation as driver of HIV persistence
From the Schiffer group, Vaccine and Infectious Disease Division
Persistent HIV infection works a lot like cancer, study shows
Ecology-inspired analysis suggests why reservoirs of HIV linger in treated patients
Guiding inactivity of latent HIV reservoirs
From the Jerome lab, Vaccine and Infectious Disease Division
Models aren’t just pretty
From the Schiffer lab, Vaccine and Infectious Disease Division
A voice for HIV cure
As researchers work toward a cure, advocate Tranisha Arzah keeps the focus on community
Good News: CBS 'Sunday Morning' to feature Dr. Jim Olson's Tumor Paint research this weekend
Celebrating faculty and staff achievements
Dr. Keith Jerome, collaborators awarded amfAR grant for HIV cure research
Team will develop nanotechnology to deliver therapies to dormant, HIV-infected cells